CTLA4 and cancer: In a recent systematic review, we provided strong evidence that malignant cells express variable levels of CTLA-4 (transcripts and functional) on the cell surface or within the cytoplasm in many types of cancer, including HNC (laryngeal and pharyngeal) [15].